HONG SENG CONSOLIDATED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.01 MYR | 0.00% |
|
-33.33% | -60.00% |
| Sales 2021 | 146M 30.62M 2.55B | Sales 2022 | 198M 41.64M 3.47B | Capitalization | 1.66B 348M 29.05B |
|---|---|---|---|---|---|
| Net income 2021 | 43M 9.02M 752M | Net income 2022 | 97M 20.36M 1.7B | EV / Sales 2021 | 41.4 x |
| Net cash position 2021 | 143M 29.93M 2.5B | Net cash position 2022 | 60.88M 12.78M 1.07B | EV / Sales 2022 | 8.06 x |
| P/E ratio 2021 |
183
x | P/E ratio 2022 |
22.7
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 39.16% |
More Fundamentals
* Assessed data
More news
| 1 week | -33.33% | ||
| 3 months | -33.33% | ||
| 6 months | -77.78% | ||
| Current year | -60.00% |
1 week
0.01
0.02
1 month
0.010.02
Current year
0.010.03
1 year
0.010.15
3 years
0.011.94
5 years
0.011.94
10 years
0.011.94
| Managers | Title | Age | Since |
|---|---|---|---|
Jaswant Singh
DFI | Director of Finance/CFO | 59 | - |
Aik Khoon Chua
SAM | Sales & Marketing | 52 | 01/97/01 |
Sor Hua Tea
SEC | Corporate Secretary | - | 01/22/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kam Soon Leong
BRD | Director/Board Member | 66 | 26/21/26 |
Hooi Guan Chan
BRD | Director/Board Member | 57 | 16/21/16 |
Li Chain Lee
BRD | Director/Board Member | 49 | 01/22/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 7 M€ | +0.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 0.01 | 0.00% | 54,133,200 |
| 25/24/25 | 0.01 | 0.00% | 8,121,200 |
| 24/24/24 | 0.01 | 0.00% | 21,375,300 |
| 23/24/23 | 0.01 | 0.00% | 6,494,700 |
| 22/24/22 | 0.01 | -33.33% | 5,374,900 |
End-of-day quote BURSA MALAYSIA, April 26, 2024
More quotes
Hong Seng Consolidated Berhad is a Malaysia-based investment holding company. The Company operates through four segments: Healthcare, Financial services, Gloves and Others. The Healthcare segment includes marketplace, medical diagnostic and research laboratory and wholesale of pharmaceutical and medical goods. The Financial services segment includes moneylending activities. The Gloves segment is engaged in the manufacturing and trading of rubber gloves. The Others segment is engaged in the investment holding, development and provision of software solutions/applications, training and seminars and other dormant companies. The Company through its subsidiaries engaged in the business of healthcare, financial services, and glove manufacturing amongst others mainly through the provisioning of a digital healthcare platform; diagnostics and health screening laboratory services; healthcare logistics solutions; moneylending facilities, and nitrile glove manufacturing and trading.
Calendar
23/05/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -60.00% | 10.71M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -3.97% | 11.66B | |
| -1.42% | 11.72B | |
| -31.75% | 11.77B |
- Stock Market
- Equities
- HONGSENG Stock
